Here are four things to know.
1. Anthem intends to repurchase up to $2 billion in shares. The payer has 265 million outstanding shares, down from 657 million in 2006, the report states.
2. Anthem is planning to invest an undisclosed amount in its business, according to the report.
3. The payer may pursue smaller acquisitions following its proposed transaction with Cigna, Indianapolis Business Journal reports. The publication points to comments made by Anthem CEO Joseph Swedish at the UBS Global Healthcare Conference in New York City on May 24. He said Anthem has “committed ourselves to being a growth company. That is first and foremost on our list of responsibilities.”
4. Anthem will plan a new pharmacy benefits management business after its contract with Express Scripts expires at the end of 2019.
More articles on payer issues:
California exchange will tell insurers to raise premiums if ACA subsidies aren’t secured
Florida Blue to sell individual ACA exchange policies for 2018
UnitedHealthcare, University of Chicago contract disagreement could affect 8k